(Q37747496)

22 August 2017

title

STAR*D: has it taught us anything about the management of depression? (English)

1 reference

22 August 2017

David Castle

1

1 reference

22 August 2017

Isaac Schweitzer

series ordinal

2

1 reference

22 August 2017

John Tiller

series ordinal

3

1 reference

22 August 2017

publication date

1 January 2009

1 reference

22 August 2017

published in

Australasian Psychiatry

1 reference

22 August 2017

volume

17

1 reference

22 August 2017

issue

5

1 reference

22 August 2017

page(s)

360-364

1 reference

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10398560903176958

Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10398560903176958

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10398560903176958

Development of a Rating Scale for Primary Depressive Illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10398560903176958

The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10398560903176958

Condensed version of the Quality of Life Scale for schizophrenia for use in outcome studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10398560903176958

Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10398560903176958

National Institute of Mental Health Treatment of Depression Collaborative Research Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10398560903176958

Effects of risperidone augmentation in patients with treatment-resistant depression: Results of open-label treatment followed by double-blind continuation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10398560903176958

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10398560903176958

What predicts attrition in second step medication treatments for depression?: a STAR*D Report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10398560903176958

10.1080/10398560903176958

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference